Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2003
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642226 Such as cis-(3,5-bis-trifluoromethyl-phenyl)-(4-(4-methyl-piperazin-1-yl),-3-phenyl -piperidin-1-yl)-methanone; for treatment of diseases related to neurokinin receptors
11/04/2003US6641834 Quinoxaline component is selected from qinoxaline, a (2-imiozoline -2-ylamino) quinoxaline, a 5-bromo-6-(2-imidozolin-2- ylamino) quinoxaline, a tartrate of 5-bromo-6-(2-imidozolin-2-ylamino) quinoxaline or derivatives
11/04/2003CA2257322C Thiazole derivatives
10/2003
10/31/2003CA2444598A1 Compositions useful as inhibitors of gsk-3
10/30/2003WO2003089583A2 Tissue specific genes and gene clusters
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089430A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003WO2003089007A1 Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
10/30/2003WO2003088992A1 Novel screening method
10/30/2003WO2003088973A1 Combination of brimonidine and timolol for topical ophthalmic use
10/30/2003WO2003088972A1 Novel compounds
10/30/2003WO2003088906A2 Methods of simultaneously treating ocular rosacea and acne rosacea
10/30/2003WO2003088900A2 Solid forms of salts with tyrosine kinase activity
10/30/2003WO2003051277A3 Novel compounds
10/30/2003WO2003047633A3 Treatment of angiogenesis disorders using targeted nanoparticles
10/30/2003WO2003039481A3 Adipose tissue-derived stromal cells for the repair of corneal and intra-orbital defects and uses thereof
10/30/2003WO2003032921A3 Treatment of neurodegenerative diseases and cancer of the brain
10/30/2003WO2003028527A3 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
10/30/2003WO2003025199A3 Mid 4460, a human tyrosine phosphatase family member and uses therefor
10/30/2003WO2003018619A3 Antimicrobial and anti-inflammatory peptides
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003011299A3 Treatment of ocular hypertension and glaucoma
10/30/2003WO2002087563A3 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002032447A3 Cell damage inhibitor
10/30/2003WO2002002638A3 Methods for treating rheumatic diseases using a soluble ctla4 molecule
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203973 Administering triethylenetetramine to lower copper value of myocardium; for treatment of diabetes
10/30/2003US20030203966 Such as N-(3,5-dimethyl-4-((nitromethyl)sulphonyl) phenyl)benzenesulphonamide for treatment/prevention of peripheral and autonomous neurolgical diabetic complications, renal and ocular disorders (cataracts, retinopathy)
10/30/2003US20030203957 Selected fused pyrrolocarbazoles
10/30/2003US20030203955 Administering to a patient suffering from an immune cell mediated diseases a therapeutic amount of biheterocyclic compound containing sulfone group or substituted suflone
10/30/2003US20030203951 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203914 Implicated as playing a key role in processes involving cellular invasion and tissue remodelling including wound repair, bone remodelling, angiogenesis, tumour invasiveness and spread of metastases
10/30/2003US20030203912 Serotonergic 5HT2 agonists for treating glaucoma
10/30/2003US20030203889 Phenylsulphonyl derivatives as 5-HT receptor ligands
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203849 Composition promoting lacrimal secretion
10/30/2003US20030203057 A mixture of isoflavones or isoflavone glycosides, pungent, bitter and sour substances and/or scymnol and scymnol esters; secretion of biogenic monoamines; antidepressants; seasonal affective disorder; Alzheimer's disease and much more!
10/30/2003US20030203034 Compositions for treating hyperemia
10/30/2003US20030203030 Polymeric gel delivery system for pharmaceuticals
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2752132A1 Thioxanthine derivatives as myeloperoxidase inhibitors
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2476792A1 Methods of simultaneously treating ocular rosacea and acne rosacea
10/29/2003EP1357115A1 Alkanoic acid derivatives, process for their production and use thereof
10/29/2003EP1356817A1 Therapeutic and/or preventive agents for diseases due to retinal ischemia
10/29/2003EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355902A1 Sulfonamide compounds, their preparation and use
10/29/2003EP1355893A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion
10/29/2003EP1355888A1 Quinazolinone derivatives
10/29/2003EP1355884A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355877A1 Process of obtaining compositions of stable lutein and lutein derivatives
10/29/2003EP1355873A1 Pleuromutilin derivatives with antimicrobial activity
10/29/2003EP1355652A2 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders
10/29/2003EP1355649A2 Pharmaceutical formulation containing pyrazolo 4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates
10/29/2003EP1355645A2 Method for treating fibrotic diseases or other indications iiic
10/29/2003EP1355631A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
10/29/2003EP1214056B1 Topical suspension formulations containing ciprofloxacin and dexamethasone
10/29/2003CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation
10/29/2003CN1452613A Amorphous torasemide modification
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451422A Chinese medicine for treating fundus oculi bleeding
10/29/2003CN1125823C Ganciclovir sodium hydrate and its preparing process and application
10/28/2003US6638976 3-benzoylphenylacetic acids and derivatives, including nepafenac, to treat neurodegenerative retinal disorders
10/28/2003US6638964 Sulfonamide-containing indole compounds
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638516 Strain selection of pneumococcal surface proteins
10/28/2003CA2253796C Inhibition of matrix metalloproteases by acetylene containing compounds
10/23/2003WO2003087818A2 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction
10/23/2003WO2003087368A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification
10/23/2003WO2003087367A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye
10/23/2003WO2003087357A2 Nucleic acid comprising retinal-specific regulatory region
10/23/2003WO2003087345A2 Stimulation of nerve cell regeneration
10/23/2003WO2003087333A2 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087090A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003WO2003087089A1 Piperidine derivatives having ccr3 antagonism
10/23/2003WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086472A1 Drugs to be used in gene therapy for recessively transmitted genetic disease
10/23/2003WO2003086465A1 Drugs for myopia correction surgery
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086428A1 Active substance mixtures of extracts of the genus vaccinium and carotene compounds
10/23/2003WO2003086407A1 Use of stimulators of soluble guanylate cyclase for treating glaucoma
1 ... 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 ... 531